| Literature DB >> 7355225 |
B D Collier, S Treves, M A Davis, S Heyman, G Subramanian, J G McAfee.
Abstract
Eight neonates with jaundice were studied simultaneously with 99mTc-p-butyl-IDA and 131I-rose bengal. Due to physical decay, 99mTc-p-butyl-IDA failed to demonstrate delayed excretion through the patent extrahepatic biliary tract in 3 of 5 patients with concomitant hepatitis; 131I-rose bengal showed small-bowel activity in all 5. Neither agent demonstrated small-bowel activity in 3 neonates with extrahepatic biliary atresia. Based on this clinical trial, 131I-rose bengal remains the radiopharmaceutical of choice for distinguishing between hepatitis and biliary atresia in these patients.Entities:
Mesh：
Substances：
Year: 1980 PMID： 7355225 DOI： 10.1148/radiology.134.3.7355225
Source DB: PubMed Journal: Radiology ISSN： 0033-8419 Impact factor: 11.105